3 articles on MDMA treatment retracted due to unethical conduct

Fierce Biotech report Psychopharmacology has pulled three articles about midstage clinical trial data assessing Lykos Therapeutics’ investigational MDMA candidate for treating post-traumatic stress disorder (PTSD). The journal cited “unethical conduct” at a research site as the reason for the retraction. The article removals are related to protocol violations at a study site that was involved in phase 2 […]